The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin
- 8 July 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 8 (8) , 2767-2776
Abstract
Recent advancements in the study of psilocybin and its active metabolite psilocin have highlighted their unique psychedelic properties and potential therapeutic applications, particularly in the rapid and sustained treatment of depression. However, the potent acute psychedelic effects of psilocybin necessitate a deeper understanding of the neural mechanisms underlying its action. In this study, we investigated the psilocin-induced neural activity in male mice using c-Fos immunofluorescent labeling and identified brain regions associated with psychedelic-like activity. Among the medial prefrontal cortex (mPFC), orbitofrontal cortex (OFC), interstitial nucleus of the posterior limb of the anterior commissure (IPAC), and dorsomedial striatum (DMS), only the mPFC was specifically associated with the head twitch response (HTR), a hallmark of psychedelic-like behavior. A picomolar dose of psilocin in the mPFC was sufficient to induce significant HTR, suggesting that c-Fos-positive neurons in this region modulate psychedelic-like activity. To validate this hypothesis, optogenetic activation of these neurons significantly increased spontaneous HTR in TRAP2 mice, whereas acute inhibition suppressed drug-induced HTR. These findings establish the mPFC as a critical regulator of psilocin-induced psychedelic-like activity and provide valuable insights for enhancing the clinical safety and therapeutic application of psychedelics.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2021ZD0203000 (2021ZD0203003))
- National Natural Science Foundation of China (T2350008)
- State Key Laboratory of Brain-Machine Intelligence, Zhejiang University (BMI2400014)
This publication has 49 references indexed in Scilit:
- Exploring the Therapeutic Potential of Psychedelics in Chronic Pain Management: A New Frontier in MedicineNeuroscience Bulletin, 2025
- Psychoactive Substances: Transforming the Paradigm for Treating Mental Health Disorders in the Post-Pandemic EraNeuroscience Bulletin, 2024
- Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialeClinicalMedicine, 2024
- Structural and functional brain alterations in anorexia nervosa:A multimodal meta‐analysis of neuroimaging studiesHuman Brain Mapping, 2021
- Calretinin Neurons in the Midline Thalamus Modulate Starvation-Induced ArousalCurrent Biology, 2018
- Increased Global Functional Connectivity Correlates with LSD-Induced Ego DissolutionCurrent Biology, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage CancerArchives of General Psychiatry, 2011
- A possible correlation between drug-induced hallucinations in man and a behavioural response in micePsychopharmacology, 1967
- Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen RauschpilzenHelvetica Chimica Acta, 1959
- Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana HeimCellular and Molecular Life Sciences, 1958